The Law Offices of Frank R. Cruz announces an investigation of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

What Is The Investigation About?
On May 5, 2026, Embecta released its second quarter fiscal 2026 financial results, revealing that revenue had declined over 14%, largely due to weakness in its pen needle sales. Additionally, the Company lowered its guidance for the remainder of fiscal 2026.

On this news, Embecta’s stock price fell $5.35, or 57.8%, to close at $3.90 per share on May 5, 2026, thereby injuring investors.